6:10 PM
 | 
Sep 12, 2012
 |  BC Extra  |  Politics & Policy

FDA lowers fee to use Priority Review voucher

FDA set the fee for companies to use a Priority Review voucher at $3.6 million for FY13, down from $5.3 million in FY12. The fee is adjusted each fiscal year to account for the difference between the average...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >